Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Assets (2016 - 2026)

Angiodynamics' Assets history spans 16 years, with the latest figure at $260.7 million for Q1 2026.

  • For Q1 2026, Assets fell 8.67% year-over-year to $260.7 million; the TTM value through Feb 2026 reached $260.7 million, down 8.67%, while the annual FY2025 figure was $280.1 million, 11.81% down from the prior year.
  • Assets reached $260.7 million in Q1 2026 per ANGO's latest filing, down from $269.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $558.2 million in Q4 2022 to a low of $260.7 million in Q1 2026.
  • Average Assets over 5 years is $404.1 million, with a median of $324.8 million recorded in 2024.
  • Peak YoY movement for Assets: rose 0.74% in 2022, then plummeted 41.65% in 2024.
  • A 5-year view of Assets shows it stood at $558.2 million in 2022, then fell by 10.5% to $499.6 million in 2023, then tumbled by 41.65% to $291.6 million in 2024, then decreased by 7.5% to $269.7 million in 2025, then decreased by 3.34% to $260.7 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Assets are $260.7 million (Q1 2026), $269.7 million (Q4 2025), and $265.6 million (Q3 2025).